Brief DBT Skills Training for Coping With Suicidal Ideation

September 2, 2025 updated by: Muhammed Ali Boztepe

Brief Dialectical Behavior Therapy-Skills Training for Coping With Suicidal Ideation: A Randomized Controlled Trial

The goal of this clinical trial is to learn if Brief Dialectical Behavior Therapy Skills Training (DBT-BST) can prevent suicidality in adults. The main questions it aims to answer are:

  • Does DBT-BST provide coping strategies (e.g., emotion regulation) to participants with suicidal ideation?
  • Does DBT-BST lower participants' suicide ideation?

Researchers will compare DBT-BST to relaxation to see if DBT-BST works to reduce suicidal ideation.

Participants will:

  • Receive DBT-BST in a single 60-minute, in-person, individual session.
  • Be asked to use these skills as self-help and for crisis prevention.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Aydın
      • Aydin, Aydın, Turkey (Türkiye), 09500
        • Aydın Adnan Menderes University, Suicide and Stress Research Laboratory

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • being 18 years of age or older
  • having suicidal ideation in the last 3 months
  • not having received any psychological treatment in the last 1 month
  • living in Aydın/Türkiye where the intervention will be implemented
  • giving consent for participation

Exclusion Criteria:

  • not speaking Turkish
  • loss or trauma in the last 1 year
  • pharmacological treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brief Dialectical Behavior Therapy-Skills Training

The intervention is administered in a single session, lasting approximately 60 minutes and conducted in person. It is important to note that there are no ongoing sessions.

In the intervention, participants are provided with 5 basic skills of Dialectical Behavior Therapy: 1) mindfulness, 2) mindfulness of current emotions, 3) opposite-to-emotion action, 4) distraction, and 5) changing body chemistry. These strategies are grouped under 3 categories: 1) Mindfulness, 2) Emotion regulation (mindfulness of current emotions, opposite-to-emotion action), 3) Tolerating distress (distraction, changing body chemistry). These skills are not designed to treat or solve the crisis. The main aim is to provide effective coping mechanisms that can be implemented quickly before the crisis escelates, to help overcome the intense emotional pain and keep the person alive.

Active Comparator: Relaxation control group
The control group will be subjected to a relaxation exercise, with the objective of managing participant expectations, researcher attention/interest, and time spent, as well as providing a coping strategy for stress.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in the Suicidality at 1 Month as Assessed by Suicide Probability Scale
Time Frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
36 is equivalent to the lowest suicidality, and 144 indicates the highest suicidality.
From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Suicidal Cognitions at 1 Month as Assessed by Suicide Cognitions Scale
Time Frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
18 is equivalent to the lowest suicidal cognitions, and 90 indicates the highest suicidal cognitions.
From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Hopelessness at 1 Month as Assessed by Beck Hopelessness Scale
Time Frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Zero is equivalent to the lowest hopelessness, and 20 indicates the highest hopelessness.
From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Emotion Regulation Skills at 1 Month as Assessed by Emotion Regulation Skills Questionnaire
Time Frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Zero is equivalent to the lowest emotion regulation skills, and 108 indicates the highest skills.
From enrollment to the end of intervention at 1 week and follow-up at 1 month
Change from Baseline in the Difficulties in Emotion Regulation at 1 Month as Assessed by Difficulties in Emotion Regulation Scale-16
Time Frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
16 is equivalent to the lowest difficulties, and 80 indicates the highest difficulties in emotion regulation.
From enrollment to the end of intervention at 1 week and follow-up at 1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in the Depression, Anxiety, and Stress at 1 Month as Assessed by Depression Anxiety Stress Scale-21 (DASS-21)
Time Frame: From enrollment to the end of intervention at 1 week and follow-up at 1 month
Higher points are equivalent to higher symptoms as assessed by the related subscale of DASS-21. Each subscale ranges from 0 to 28.
From enrollment to the end of intervention at 1 week and follow-up at 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 1, 2025

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

January 1, 2026

Study Registration Dates

First Submitted

June 18, 2025

First Submitted That Met QC Criteria

June 18, 2025

First Posted (Actual)

June 26, 2025

Study Record Updates

Last Update Posted (Estimated)

September 8, 2025

Last Update Submitted That Met QC Criteria

September 2, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • BriefDBT-ST30/05/2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Coping Skills

Clinical Trials on Brief Dialectical Behavior Therapy-Skills Training

Subscribe